论文部分内容阅读
目的探讨原发性肝癌采用精准肝切除术治疗的临床效果。方法对2014年8月—2016年10月洛阳中心医院收治的88例原发性肝癌患者的一般资料进行回顾性分析,所有患者均经临床检查,确诊为原发性肝癌。且患者及家属均对本研究知情同意。按照手术方法的不同,将88例患者分为研究组(精准肝切除术)与对照组(常规肝切除术)。对比两组治疗效果。结果研究组术中出血量、住院时间均少于对照组,差异显著(P<0.05);但研究组手术时间长于对照组,差异显著(P<0.05);治疗后,两组ALT、AST、ALB、TBIL水平差异显著(P<0.05);两组并发症发生率差异显著(P<0.05)。结论在原发性肝癌患者的临床治疗过程中,采用精准肝切除术治疗的效果显著,值得推广应用。
Objective To investigate the clinical effect of precision hepatectomy on primary liver cancer. Methods The data of 88 patients with primary liver cancer admitted from August 2014 to October 2016 in Luoyang Central Hospital were retrospectively analyzed. All the patients were diagnosed as primary liver cancer by clinical examination. Both patients and their families informed the study. According to the different surgical methods, 88 patients were divided into study group (precision hepatectomy) and control group (conventional hepatectomy). Compare the two groups treatment effect. Results The bleeding volume and hospital stay in the study group were less than those in the control group (P <0.05), but the study group had longer operation time than the control group (P <0.05). After treatment, the ALT, AST, The ALB and TBIL levels were significantly different (P <0.05). The incidence of complications was significantly different between the two groups (P <0.05). Conclusion In the course of clinical treatment of patients with primary liver cancer, the effect of precision hepatectomy is significant and it is worth popularizing and applying.